Breast Cancer Recurrence Still a Threat Decades After Completing 5 Years' Endocrine Therapy

Women with estrogen-receptor (ER)-positive, early-stage breast cancer who receive 5 years of adjuvant endocrine therapy are still at risk for recurrence up...
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news